Health TrialsbyHealthPanel

Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)

1

Review clinical trials related to Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)

This is an open-label, dose escalation and expansion, multi-center phase 2 study evaluating the safety and efficacy of SR-8541A administered orally in combination with intravenous botensilimab and balstilimab in subjects with MSS-CRC with and without active liver metastases.

Participants needed: 70
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Stingray TherapeuticsUpdated: Aug 12, 2026Locations: 6
Eligibility criteria

Written informed consent from subject [+13]

Hypersensitivity or allergy to any of the study drugs or their excipients. [+33]

Read more